Hudson River Biotechnology
PrivateLast Round
VC Round
Apr 9, 2024
Total Funding Raised
$5.99M
Company Overview
Hudson River Biotechnology is an agricultural biotechnology company that develops new crop varieties using its proprietary DNA-free CRISPR platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hudson River Biotechnology Comparables
Compare Hudson River Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phytoform Labs | 87% | |
| Qi Biodesign | 84% | |
| Pairwise | 82% |
Hudson River Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 9, 2024 | ||||
| VC Round | Apr 9, 2024 | ||||
| Series A | Aug 5, 2021 | ||||
| Seed | Mar 21, 2018 | ||||
| Grant | Mar 18, 2015 |
Hudson River Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Bridford Group | VC Round, Series A |
| Oost NL | VC Round |
| StartLife | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2024
Oost NL and Bridford Group led the round.
- Apr 9, 2024
Oost NL and Bridford Group led the round.
Hudson River Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hudson River Biotechnology's valuation, stock price, and market status.
Is Hudson River Biotechnology a public or private company?
Hudson River Biotechnology is a private company.
What is the current stock price of Hudson River Biotechnology?
Hudson River Biotechnology is a private company, so its shares have no public market price. Caplight tracks Hudson River Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hudson River Biotechnology worth (valuation)?
Valuation information for Hudson River Biotechnology is not publicly available.
Can I buy Hudson River Biotechnology stock?
Hudson River Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hudson River Biotechnology's last funding round?
Hudson River Biotechnology's most recent funding round was VC Round on April 9, 2024.
Who are the main investors in Hudson River Biotechnology?
Key investors in Hudson River Biotechnology include Bridford Group, Oost NL.
Will Hudson River Biotechnology IPO soon?
No public IPO plans have been announced for Hudson River Biotechnology.
How can I track Hudson River Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Hudson River Biotechnology's shares on secondary markets.